Alembic announces seed round investment in RIGImmune, Inc. Kumar Jeetendra | December 10, 2021 10th December, 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) has announced today that it has made a strategic investment in RIGImmune Inc., a biopharmaceutical research company co-founded by two prominent Yale University professors. RIGImmune Inc. was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki. Dr. Pyle is a Professor of Molecular, Cellular and Developmental Biology …
Cytel and Pulse Infoframe Deploy New Real-World Data Solutions to Transform Rare Disease Research Landscape Kumar Jeetendra | December 9, 2021 Waltham, MA, December 9, 2021 – A collaboration between Cytel and Pulse Infoframe creates a solution that marks a new direction in research for rare disease. This partnership will support drug development sponsors seeking to implement real-world evidence solutions where the data generated can be used for a range of purposes, from synthetic controls and …
Fortis Hospitals, Bangalore conducts “Guardians of Health” HR Conclave to reinvent the role of HR in the new normal Kumar Jeetendra | November 27, 2021 Bangalore, November, 27,2021: With an aim to help the HRs create a healthy and meaningful version of the new normal, Fortis Hospitals, Bangalore conducted Guardians of Health, HR Conclave 2021. The focus of the conclave was Reinventing the role of HR in the new normal amidst resumption of the offices post second wave of Covid-19. …
Eppendorf donates 20,000 euros to the EMBL to promote women working in science Kumar Jeetendra | November 26, 2021 Eppendorf SE donated 20,000 euros to the European Molecular Biology Laboratory (EMBL) during an online presentation ceremony. The funds are for the EMBL project “Advancement of Women in Science,” which enables women scientists to begin managerial careers in scientific fields. In her remarks thanking the company for the donation, Edith Heard, the Director General of …
Concept Life Sciences celebrates GMP accreditation Kumar Jeetendra | November 22, 2021 Sandwich, Kent – 22 November 2021 – Concept Life Sciences (CLS), a Malvern Panalytical brand, today announced that it has received certification of compliance with Good Manufacturing Practice (GMP) for the production of active substances at its site in Sandwich, UK. This is the successful outcome of an in-depth Medicines and Healthcare products Regulatory Agency …
Dr Gangadhar M. Warke, Founder & CMD, HiMedia Laboratories, is honoured as ‘The First Fellow’ of Microbiologists Society, India Kumar Jeetendra | November 18, 2021 The Microbiologists Society of India (MSI) has awarded Dr. Gangadhar M. Warke, Founder & CMD, HiMedia Laboratories with the ‘First Fellow of MSI’. The fellowship was awarded in appreciation for his extensive contribution towards the Indian microbiology industry, and allied sciences, his outstanding direction, leadership and dedicated services as the founder of the media making …
Biofortuna double their manufacturing capacity Kumar Jeetendra | November 3, 2021 3 November 2021 – Life Science Newswire – Biofortuna (Deeside UK), a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales. The purpose-built facilities have been designed by the Company to …
Thermo Fisher Scientific transitions its chemicals brand product portfolio Kumar Jeetendra | November 2, 2021 MUMBAI, India – (Nov 01, 2021) – Thermo Fisher Scientific, the world leader in serving science recently announced consolidation of its product portfolio brands Acros Organics, Alfa Aesar and Maybridge transitioning to one unified brand, Thermo Scientific™. This transition is a response to the customer’s feedback to simplify the buying journey experience. The transition will …
Ubiquigent extends and expands drug discovery collaboration with Bristol Myers Squibb Kumar Jeetendra | October 26, 2021 Dundee, UK, 26th October 2021 – Ubiquigent Limited (Ubiquigent) today announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide Bristol Myers Squibb with increased access to its deubiquitylase (DUB) enzyme inhibitor drug discovery platform to provide further support to additional therapeutic areas. …
We are Pioneer Group and Astellas Announce Future Innovator Prize to Help Emerging Biotechs Accelerate Early Drug Discovery and Research Efforts Kumar Jeetendra | October 21, 2021 TOKYO and NOTTINGHAM, UK – 21 October 2021 – Life Science Newswire – Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc, and We are Pioneer Group (WAPG), the UK’s largest ecosystem provider for science and innovation businesses, today announce a new collaborative sponsorship and first of its kind initiative to …
Cipla secures a spot among the top global employers in Forbes’ “World’s Best Employers 2021” list Kumar Jeetendra | October 15, 2021 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) has emerged as the only Indian pharma company to secure a spot in the Forbes “World’s Best Employers 2021” list among the top global employers across 58 countries. Cipla also features as the sole Indian player being featured as a part of …
Xuanzhu and SignalChem Lifesciences Corporation Announce Collaboration and Licensing Agreement for SLC-391 in the Greater China Region Kumar Jeetendra | September 27, 2021 September 27, 2021 – Beijing, China and Richmond, British Columbia, Canada – Life Science Newswire – Sihuan Pharmaceutical Holdings Group Ltd., together with its subsidiaries and SignalChem Lifesciences Corporation today announced that Sihuan Pharmaceutical Holdings Group Ltd subsidiary company Xuanzhu Biopharmaceutical Co., Ltd. (“Xuanzhu”) and SignalChem Lifesciences Corporation (“SignalChem”) have entered into an exclusive collaboration …
